[c09aa8]: / clusters / 9knumclustersv2 / clust_1724.txt

Download this file

22 lines (21 with data), 2.2 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
Any other radiotherapy or radionuclide require -day washout prior to first dose of study drug
The participant has received radionuclide treatment within weeks of the first dose of study treatment
Radionuclide treatment within weeks of the first dose of study drug in this study
mCRPC EXPANSION COHORT: The patient has received radionuclide treatment within weeks prior to the first dose of the study treatment
Received radionuclide treatment (i.e. iodine [I]- meta-iodo-benzyl guanidine) within months of the first dose of study treatment
The subject has received radionuclide treatment within weeks of the first dose of study treatment
The subject has received radionuclide treatment within weeks of the first dose of study treatment
The subject has received radionuclide treatment within weeks of the first dose of study treatment
No prior radionuclide treatment within weeks of the first dose of study treatment
Radionuclide treatment, including yttrium- treatment, within weeks of the first dose of study treatment
The subject has received radionuclide treatment within weeks before the first dose of study treatment
Systemic therapeutic radionuclide delivery within days prior to treatment
The subject has received radionuclide treatment within weeks prior to the first dose of the study treatment
Biological agents (antibodies, immune modulators, cytokines, or vaccines) or radionuclide treatment within weeks of the first dose of study treatment
The participant has received radionuclide treatment within weeks of the first dose of study treatment
Cannot have received radionuclide treatment within weeks of first dose of study treatment
The subject has received radionuclide treatment within weeks of the first dose of study treatment
The subject has received radionuclide treatment within weeks of the first dose of study treatment
The subject has received radionuclide treatment within weeks of the first dose of study treatment
The subject has received radionuclide treatment within weeks of the first dose of study treatment
Major surgery or other loco regional treatment within weeks before the first dose of study drug or radionuclide treatment within weeks